Fulgent Genetics Total Current Assets 2015-2025 | FLGT
Fulgent Genetics total current assets from 2015 to 2025. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
| Fulgent Genetics Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $354 |
| 2023 | $508 |
| 2022 | $628 |
| 2021 | $612 |
| 2020 | $524 |
| 2019 | $37 |
| 2018 | $40 |
| 2017 | $33 |
| 2016 | $26 |
| 2015 | $3 |
| 2014 | $1 |
| Fulgent Genetics Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $417 |
| 2024-12-31 | $354 |
| 2024-09-30 | $327 |
| 2024-06-30 | $399 |
| 2024-03-31 | $387 |
| 2023-12-31 | $508 |
| 2023-09-30 | $550 |
| 2023-06-30 | $528 |
| 2023-03-31 | $581 |
| 2022-12-31 | $628 |
| 2022-09-30 | $697 |
| 2022-06-30 | $675 |
| 2022-03-31 | $765 |
| 2021-12-31 | $612 |
| 2021-09-30 | $623 |
| 2021-06-30 | $567 |
| 2021-03-31 | $659 |
| 2020-12-31 | $524 |
| 2020-09-30 | $196 |
| 2020-06-30 | $41 |
| 2020-03-31 | $37 |
| 2019-12-31 | $37 |
| 2019-09-30 | $39 |
| 2019-06-30 | $35 |
| 2019-03-31 | $36 |
| 2018-12-31 | $40 |
| 2018-09-30 | $41 |
| 2018-06-30 | $38 |
| 2018-03-31 | $36 |
| 2017-12-31 | $33 |
| 2017-09-30 | $32 |
| 2017-06-30 | $35 |
| 2017-03-31 | $33 |
| 2016-12-31 | $26 |
| 2016-09-30 | $17 |
| 2016-06-30 | $22 |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2014-12-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.549B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.813B | 60.83 |
| Hims & Hers Health (HIMS) | United States | $13.134B | 136.46 |
| Doximity (DOCS) | United States | $11.457B | 53.04 |
| Tempus AI (TEM) | United States | $10.733B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.377B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.856B | 60.24 |
| Hinge Health (HNGE) | United States | $3.535B | 0.00 |
| Privia Health (PRVA) | United States | $2.402B | 164.17 |
| 10x Genomics (TXG) | United States | $1.803B | 0.00 |
| Schrodinger (SDGR) | United States | $1.643B | 0.00 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Azenta (AZTA) | United States | $1.562B | 72.62 |
| Enovis (ENOV) | United States | $1.561B | 8.70 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Omnicell (OMCL) | United States | $1.358B | 23.97 |
| Evolent Health (EVH) | United States | $1.133B | 96.50 |
| Claritev (CTEV) | United States | $0.664B | 0.00 |
| Standard BioTools (LAB) | United States | $0.539B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.480B | 0.00 |
| Talkspace (TALK) | United States | $0.428B | 128.00 |
| TruBridge (TBRG) | United States | $0.347B | 771.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.285B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.244B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.224B | 0.00 |
| CapsoVision (CV) | United States | $0.202B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.157B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.120B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.080B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |